[1] |
WU Wen, ZHANG Ruoxin, WENG Junyong, MA Yanlei, CAI Guoxiang, LI Xinxiang, YANG Yongzhi.
Exploring the prognostic value of positive lymph node ratio in stage Ⅲ colorectal cancer patients and establishing a predictive model
[J]. China Oncology, 2024, 34(9): 873-880.
|
[2] |
LIAO Ziyi, PENG Yang, ZENG Beilei, MA Yingying, ZENG Li, GAN Kelun, MA Daiyuan.
Analysis of pathological remission degree and influencing factors of radical surgery after neoadjuvant immunotherapy combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
[J]. China Oncology, 2024, 34(7): 669-679.
|
[3] |
SHI Jialu, ZHU Tingting, TAO Xiang, MA Fenghua, LIN Zhi, SHAO Jun, ZHAO Yuqing.
Retrospective analysis of 12 cases of low grade extrauterine endometrial stromal sarcoma and literature review
[J]. China Oncology, 2024, 34(4): 418-424.
|
[4] |
XU Yonghu, XU Dazhi.
Progress and prospects of gastric cancer treatment in the 21st century
[J]. China Oncology, 2024, 34(3): 239-249.
|
[5] |
XUE Chi, GAO Peng, ZHU Zhi, WANG Zhenning.
Application and challenge of immunotherapy in perioperative therapy of gastric cancer
[J]. China Oncology, 2024, 34(3): 259-267.
|
[6] |
QU Guolun, ZHANG Ruming, CHEN Yong, QU Xinglong, ZHANG Hongqiang, WANG Hongbo, WANG Kangwei, PENG Shuai.
Surgical margin and efficacy evaluation of barrier resection for soft tissue sarcoma of extremities in 72 cases
[J]. China Oncology, 2024, 34(3): 293-298.
|
[7] |
CHEN Jinjuan, WANG Xingran, LI Wenzhi, CHENG Yu, SUN Yihua, TAO Xiang, MA Fenghua, SUN Li, ZHAO Hongbo, LU Xin.
Conservative surgery in stage I placental site trophoblastic tumor: a report of 10 cases and literature review
[J]. China Oncology, 2023, 33(9): 857-865.
|
[8] |
CHEN Luyan, WANG Lixue, FU Peifen.
The value of surgery in the patients with de novo stage Ⅳ breast cancer
[J]. China Oncology, 2023, 33(5): 431-436.
|
[9] |
BI Zhao, CHEN Peng, QIU Pengfei, CHEN Yuguang, WANG Yongsheng.
The analysis of axillary lymph nodes metastasis after neoadjuvant therapy in breast cancer
[J]. China Oncology, 2023, 33(4): 361-367.
|
[10] |
LI Feng, TANG Xuehu, ZENG Bang, CHEN Minghua.
Influencing factors of cardiovascular adverse events risk in elderly patients with esophageal cancer undergoing video-assisted thoracoscopic surgery and nomogram prediction model construction
[J]. China Oncology, 2023, 33(3): 282-287.
|
[11] |
Society of Male Reproductive System Oncology, China Anti-Cancer Association.
Expert consensus on perioperative comprehensive treatment for high risk prostate cancer (2023 edition)
[J]. China Oncology, 2023, 33(12): 1204-1214.
|
[12] |
SHI Rongliang, ZHANG Tingting, WANG Yu, NI Zhaoxian, WANG Hui, WANG Yulong, WEI Wenjun, XIANG Jun, QU Ning, LU Zhongwu, FAN Juan, GU Weijin, JI Qinghai.
Clinical application analysis of Da Vinci Xi robot in thyroid surgery using a gasless, unilateral axillary approach
[J]. China Oncology, 2023, 33(11): 1018-1025.
|
[13] |
LIU Wensheng, JI Shunrong, ZHUO Qifeng, GAO Heli, SHI Yihua, XU Wenyan, LIU Mengqi, LI Zheng, YU Xianjun, CHEN Jie, XU Xiaowu.
Clinical study of robot and laparoscopic minimally invasive surgery for well-differentiated pancreatic neuroendocrine tumors
[J]. China Oncology, 2022, 32(9): 786-793.
|
[14] |
Committee of Breast Cancer Society, Chinese Anti-Cancer Association, Breast Surgeons Committee of Surgeons Branch, Chinese Medical Doctor Association, Committee of Breast Cancer Society, Shanghai Anti-Cancer Association.
Expert consensus on oncoplastic surgery of breast tumor and breast reconstruction (2022 edition)
[J]. China Oncology, 2022, 32(9): 836-924.
|
[15] |
CHEN Anli, SHEN Haoyuan, YANG Shixiong, DENG Chunyan, HU Chaohua, LIU Hanzhong, WANG Shu, QIAN Fang.
Predictive value of plasma long non-coding RNA H19 in neoadjuvant therapy for breast cancer
[J]. China Oncology, 2022, 32(8): 727-735.
|